Makiala-Mandanda S., Abbate J. L., Pukuta-Simbu E., Ahuka-Mundeke S., Muyembe-Tamfum J. J., Leroy Eric, Becquart Pierre. (2021). Herpes infections in suspected cases of yellow fever in the Democratic Republic of the Congo. Medicina, 57 (9), 871 [6 p.]. ISSN 1010-660X.
Titre du document
Herpes infections in suspected cases of yellow fever in the Democratic Republic of the Congo
Makiala-Mandanda S., Abbate J. L., Pukuta-Simbu E., Ahuka-Mundeke S., Muyembe-Tamfum J. J., Leroy Eric, Becquart Pierre
Source
Medicina, 2021,
57 (9), 871 [6 p.] ISSN 1010-660X
In the battle to quickly identify potential yellow fever arbovirus outbreaks in the Democratic Republic of the Congo, active syndromic surveillance of acute febrile jaundice patients across the country is a powerful tool. However, patients who test negative for yellow fever virus infection are too often left without a diagnosis. By retroactively screening samples for other potential viral infections, we can both try to find sources of patient disease and gain information on how commonly they may occur and co-occur. Several human arboviruses have previously been identified, but there remain many other viral families that could be responsible for acute febrile jaundice. Here, we assessed the prevalence of human herpes viruses (HHVs) in these acute febrile jaundice disease samples. Total viral DNA was extracted from serum of 451 patients with acute febrile jaundice. We used real-time quantitative PCR to test all specimens for cytomegalovirus (CMV), herpes simplex virus (HSV), human herpes virus type 6 (HHV-6) and varicella-zoster virus (VZV). We found 21.3% had active HHV replication (13.1%, 2.4%, 6.2% and 2.4% were positive for CMV, HSV, HHV-6 and VZV, respectively), and that nearly half (45.8%) of these infections were characterized by co-infection either among HHVs or between HHVs and other viral infection, sometimes associated with acute febrile jaundice previously identified. Our results show that the role of HHV primary infection or reactivation in contributing to acute febrile jaundice disease identified through the yellow fever surveillance program should be routinely considered in diagnosing these patients.
